China's top wearable firm made its NYSE debut Thursday, closing up over 2% despite the Dow's 1,000 point drop. Tim Stenovec spoke with David Cui, CFO of Huami, to discuss the company's decision to go public.
Huami is a biometric and activity data-driven company with a focus in smart wearable technology. The company shipped 11.6 million units of smart wearable devices in the first nine months of 2017, more than any other company in the world, according to Frost & Sullivan. Cui explained how the company plans to gain a bigger marketshare of the global market.
Huami has been the sole partner of Xiaomi, a mobile internet company and global consumer electronics brand. Xiaomi is now one of the largest unicorn companies in the world and is expected to go public in 2018. Cui described the special partnership and how Huami will continue to capitalize on the rapidly growing smart wearable market in China.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
